No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Rat (Rattus) RAD51C Antibodies:
anti-Mouse (Murine) RAD51C Antibodies:
anti-Human RAD51C Antibodies:
Go to our pre-filtered search.
Human Monoclonal RAD51C Primary Antibody for CyTOF, FACS - ABIN151297
Masson, Tarsounas, Stasiak, Stasiak, Shah, McIlwraith, Benson, West: Identification and purification of two distinct complexes containing the five RAD51 paralogs. in Genes & development 2001
Show all 26 Pubmed References
Monoclonal RAD51C Primary Antibody for WB - ABIN534110
Kuznetsov, Pellegrini, Shuda, Fernandez-Capetillo, Liu, Martin, Burkett, Southon, Pati, Tessarollo, West, Donovan, Nussenzweig, Sharan: RAD51C deficiency in mice results in early prophase I arrest in males and sister chromatid separation at metaphase II in females. in The Journal of cell biology 2007
Show all 5 Pubmed References
Human Polyclonal RAD51C Primary Antibody for IHC (p), ELISA - ABIN249699
Dosanjh, Collins, Fan, Lennon, Albala, Shen, Schild: Isolation and characterization of RAD51C, a new human member of the RAD51 family of related genes. in Nucleic acids research 1998
AtRAD51C and SWI may function at distinct stages of meiosis.
AtRAD51C is essential for normal meiosis and is probably required for homologous synapsis.[AtRAD51C]
Crossing of RAD51C mutant with wild-type plants showed defective male and female gametogeneses as evidenced by lack of seed production. Furthermore, meiosis was severely disturbed in the mutant.
Similar to other BC models, Rad51c/p53 double-mutant mouse mammary tumors also reveal a propensity for genomic instability, but lack the focal amplification of the Met locus or distinct mutational signatures reported for other HR genes
a critical synergy between Rad51c and Trp53 in tumour progression and provide a predictable in vivo model system for studying mechanisms of Rad51c-mediated carcinogenesis
These results imply that adequate expression of Rad51C in mammalian cells is essential for maintaining genomic stability and sister chromatid cohesion to prevent malignant transformation.
the RAD51C-XRCC3-associated Holliday junction resolvase complex associates with crossovers and may play an essential role in the resolution of recombination intermediates prior to chromosome segregation
RAD51C has a late role in meiotic recombination.
Rad51c mutation in DH-cis mice promoted the development of tumors of specialized sebaceous glands and suppressed tumors characteristic of Trp53 mutation. In addition, DH-cis females developed tumors significantly earlier than any other group.
DNA replication licensing factor MCM2 and DNA mismatch repair (MMR) protein MSH2 were confirmed to be present in co-precipitations with MmRAD51C.
The duplication associated with ovarian cancer risk (3/590 of all ovarian cancer patients, 0.5%, P = .032 compared with controls) and was found to represent a large fraction of all identified RAD51C mutations in the Finnish population. Our data emphasizes the importance of comprehensive mutation analysis including CNV detection in all the relevant genes.
Metastatic Prostate Cancer in a RAD51C Mutation Carrier.
Our results validate the integration of PALB2, RAD51C, and RAD51D in the diagnosis of hereditary breast and ovarian cancer and suggest that the other genes are involved in an oligogenic determinism.
A direct role of RAD51C in maintaining mtDNA integrity under replication stress conditions.Nucleus-independent function of RAD51C in mitochondrial genome maintenance.
results increase our knowledge about the RAD51C and RAD51D mutation spectrum and support the notion that these genes should be included in the gene panel testing performed on patients with hereditary breast and ovarian cancer syndrome
The authors assessed whether RAD51C promoter hypermethylation like mutation was associated with increased survival or increased sensitivity to platinum chemotherapy. However the results showed that neither outcomes were met
novel splice-site mutations affect the last nucleotide of exon 2 (c.404G>C, c.404G>T) and disrupt proper RAD51C pre-mRNA processing.
We showed that the mutation frequency of RAD51C in Japanese familial breast cancer cases was similar to that in Western countries and that the prevalence of deleterious mutation of PALB2 was possibly lower. Furthermore, our results suggested that BRIP1 mutation frequency in Japan might differ from that in Western countries
Here we report yet another example of a rare RAD51C missense change (p.Arg312Trp) that impairs protein function.
Using the human mammary epithelial cell line MCF10A, we show that deletion of TP53 can rescue RAD51C-deficient cells from radiation-induced cellular senescence, whereas it exacerbates their centrosome amplification and nuclear abnormalities
Results identified a chromosomal translocation between Rad51C and Ataxin-7 in colorectal tumors. The in-frame fusion transcript results in a fusion protein with molecular weight of 110 KDa. In vitro 5-Azacytidine treatment of colorectal tumor cells showed expression of the fusion gene is regulated by promoter methylation.
Germline mutation in RAD51C gene is associated with neoadjuvant therapy response in triple negative breast patients.
Germline RAD51C mutation was found in patients with hereditary and sporadic gastric cancer.
individuals with mutations in RAD51C that are exposed to estrogen would be more susceptible to accumulation of DNA damage, leading to cancer progression.
Overexpression of RAD51C is associated with resistance to cisplatin and radiation in non-small cell lung cancer.
RAD51C mutations were identified in 0.5 % of Danish families.
RAD51C mutation is not associated with high-risk patients from Serbian hereditary breast/ovarian cancer.
a mutation analysis in 171 high-risk BRCA1 and BRCA2 negative ovarian cancer patients, to evaluate the frequency of hereditary RAD51C and RAD51D variants in Czech population, is reported.
Novel Rad51C splice variants occur in colorectal tumors and cells: Variant 1 without exon-7, Variant 2 without exon 6 and 7 , or Variant 3 without exon 7 and 8. They are associated with FANCD2 foci positive colorectal tumors and microsatellite stability.
conclude that the woman has two potential disease-causing mutations and that predictive testing of family members should include both the RAD51C and BRCA2 mutation
This gene is a member of the RAD51 family of related genes, which encode strand-transfer proteins thought to be involved in recombinational repair of damaged DNA and in meiotic recombination. This gene product interacts with two other DNA repair proteins, encoded by RAD51B and XRCC3, but not with itself. The protein copurifies with XRCC3 protein in a complex, reflecting their endogenous association and suggesting a cooperative role during recombinational repair. This gene is one of four localized to a region of chromosome 17q23 where amplification occurs frequently in breast tumors. Overexpression of the four genes during amplification has been observed and suggests a possible role in tumor progression. Alternative splicing has been observed for this gene and two variants encoding different isoforms have been identified.
Rad51 homolog c
, RAD51 homolog C
, RAD51 homolog C (S. cerevisiae)
, DNA repair protein RAD51 homolog 3
, Rad51 DNA recombinase 3
, RAD51C protein
, RAD51-like protein 2
, yeast RAD51 homolog 3